A case of complete revascularization with nine sirolimus eluting stents.
Patients with multivessel disease and LV dysfunction are conventionally treated with coronary artery bypass surgery. With the advent of drug eluting stents, complex lesions are now being tackled percutaneously. The ARTS II registry demonstrated the efficacy and safety of sirolimus-eluting stents (SES) in patients with multivessel disease. We report a case of "complete revascularization" with 9 sirolimus-eluting stents in a patient with multivessel disease and LV dysfunction with an angiographic evaluation at 6 months and 1 year.
Bardhan
A K
AK
Apollo Gleneagles Hospitals, Kolkata, India. drasimbardhan@rediffmail.com
Khan
Aftab
A
D003324:Coronary Artery Disease / Q000188:drug therapy* / Q000628:therapy; D054855:Drug-Eluting Stents; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D009204:Myocardial Revascularization; D020123:Sirolimus / Q000627:therapeutic use*; D018487:Ventricular Dysfunction, Left
D007166:Immunosuppressive Agents; D020123:Sirolimus